Liting Xue - Simcere Pharmaceutical | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PS15-01: A First-in-human Phase 1 Study of SIM0270, a Brain-Penetrant Oral Selective Estrogen Receptor Degrader (SERD), in Patients with ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Jiong Wu,Jian Zhang,Qingyuan Zhang,Yuping Sun, Hongtao Li,Yongmei Yin,Yehui Shi,Wenfeng Li,Yunjiang Liu,Min Yan,Chen Yang, Lili Zhu, Yang,Liting Xue

Cancer Researchno. 9_Supplement (2024): PS15-01

引用0浏览0引用

Abstract 7278: Discovery of a Novel WRN Inhibitor, ZM-3329 That Efficiently Inhibits MSI-H Tumor Growth

Feng Zhou,Guimei Yang, Yajing Liu,Liting Xue, Yao Guo,Zhengtao Li, Weikun Wang, Jian Li,Renhong Tang

Cancer Research（2024）

引用0浏览0引用

SCR-7952, a Highly Selective MAT2A Inhibitor, Demonstrates Synergistic Antitumor Activities in Combination with the S-adenosylmethionine-competitive or the Methylthioadenosine-Cooperative Protein Arginine Methyltransferase 5 Inhibitors in Methylthioadenosine Phosphorylase-Deleted Tumors

Zhiyong Yu, Yi Kuang,Liting Xue,Xuan Ma, Tingting Li, Linlin Yuan, Mengying Li, Grace Xue, Zhen Li,Feng Tang,Jianxing Tang, Jinwen Shan,Weijie Wang,Renhong Tang, Feng Zhou

MEDCOMMno. 10 (2024)

引用0浏览0WOS引用

Abstract 661: an Oral Cbl-b Inhibitor with Sustained T Cell Activation Demonstrated Robust Anti-Tumor Efficacy along with Enhanced Infiltration and Activation of Functional T Cells

Feng Zhou,Guimei Yang, Yajing Liu,Liting Xue, Weijie Chen,Zhengtao Li, Xiaowu Liu, Jian Li,Renhong Tang

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract 5946: ZM-412, a potent and selective KIF18A inhibitor with robust efficacy as monotherapy in CIN-positive tumors and in combination with MMAE-conjugated ADC in CIN-negative tumors

Feng Zhou, Lei Zhou, Ruina Wang,Liting Xue,Xiaokang Qin,Zhengtao Li, Jian Yu,Renhong Tang

Cancer Researchno. 6_Supplement (2024): 5946-5946

引用0浏览0引用

Technical Considerations and Strategies for Generating and Optimizing Humanized Mouse Tumor Models in Immuno-Oncology Research

Wenjing Li, Chunlei Xia, Kun Wang,Liting Xue,Yan Wang, Janine Y. Yang,Mingkun Zhang,Ming Yin,Zhenchuan Miao, Ying Li,Xiaofeng Zhao, Zhijian Yang,Renhong Tang,Wenqing Yang

International Immunopharmacology (2024): 112722-112722

引用0浏览0WOS引用

Abstract 591: Discovery of ZM-2322, a Highly Selective, Potent Inhibitor of Membrane-Associated Tyrosine- and Threonine-Specific Cdc2-Inhibitory Kinase (PKMYT1)

Feng Zhou, Lu Liu,Lei Jiang,Baoying Cheng, Zhentao Li, Dongxing Zhu, Jianbin Xue,Liting Xue,Renhong Tang

Cancer Researchno. 6_Supplement (2024): 591-591

引用0浏览0引用

Abstract LB271: Synergistic Anti-Tumor Efficacy in Olaparib-Sensitive and -Resistant Models Via Simultaneously Inhibition of USP1 and PARP

Shuqun Yang,Zhengtao Li,Lei Zhou, Feng Zhou,Xiaokang Qin,Liting Xue, Piaopiao Xu,Jianxing Tang, Wendy Wang,Renhong Tang

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Abstract 4539: ZM-2311 a Novel and Highly Potent Polθ Inhibitor Demonstrates Synergistically Anti-Tumor Activities in Combination with Different Therapeutics

Feng Zhou, Lu Liu,Lei Jiang, Shuo Qian,Liting Xue, Mengying Li,Zhengtao Li, Zhen Li, Jian Li,Renhong Tang

Cancer Researchno. 6_Supplement (2024): 4539-4539

引用0浏览0引用

Abstract 3474: Identification of the Selective CBL-b Inhibitors Which Effectively Prevent T Cells from Exhaustion and Demonstrate Synergistic Anti-Tumor Activity in Combination with an Anti-Pd1 Antibody

Feng Zhou,Zhengtao Li, Yajing Liu,Guimei Yang,Wansun Mai,Wenqing Yang,Liting Xue,Ping Chen,Renhong Tang

Cancer Researchno. 7_Supplement (2023): 3474-3474

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn